The molecular pathogenesis of LAM is based onTSC2 gene mutations and their effect on the mTOR pathway, which is normally controlled by the protein complex (hamartin/tuberin) encoded byTSC1 andTSC2 genes, respectively12,13. Here, MTOR is linked to lymphangioleiomyomatosis.